Related Experiment Video
Updated: Oct 26, 2025

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
Hypertrophic Cardiomyopathy in Adolescence: Application of Guidelines
Paul F Kantor1, Timothy W Casarez1,2, Yaniv Bar-Cohen1
1Division of Cardiology, Department of Pediatrics, Children's Hospital of Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Insights
This case study highlights the management of adolescent hypertrophic cardiomyopathy. Early screening and risk stratification are crucial for timely defibrillator implantation in affected individuals.
Area of Science:
- Cardiology
- Genetics
- Adolescent Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease often presenting in adolescence.
- Early identification and management are critical to prevent adverse outcomes.
- This case focuses on the clinical course and therapeutic strategies for an adolescent male diagnosed with HCM.
Observation:
- The patient was an adolescent male with a confirmed diagnosis of hypertrophic cardiomyopathy.
- Key clinical features and diagnostic evaluations were meticulously documented.
- The importance of a comprehensive family history was underscored in the diagnostic process.
Findings:
- Accurate evaluation of cardiac hypertrophy is essential for diagnosis and management.
- Risk stratification is vital for determining eligibility for implantable cardioverter-defibrillators (ICDs).
- The case illustrates the application of current guidelines in managing HCM.
Implications:
- Emphasizes the need for early screening protocols in at-risk adolescent populations.
- Highlights the role of genetic counseling and family history in HCM management.
- Reinforces the importance of individualized risk assessment for ICD implantation in young patients with HCM.
Abstract:
We present the course and management of an adolescent male with hypertrophic cardiomyopathy. The importance of family history, early screening, accurate evaluation of hypertrophy, and risk stratification for eligibility for a defibrillator in hypertrophic cardiomyopathy are emphasized. Learning points are seen in the light of new guidelines. (Level of Difficulty: Intermediate.).
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management

